the global Medical and Research Grade Collagen market is speculated to be worth US$ 884.2 Mn by 2027, says The Insight Partners
Medical and Research Grade Collagen Market to 2027 - Global Analysis and Forecasts by Source (Bovine, Porcine, Poultry, Marine, Others); By Product (Gelatin, Hydrolyzed Collagen, Native Collagen, Others); By Application (Haemostats, Vascular Grafts, Tissue Scaffolds, Cartilage Repair, Wound Care, Bone Grafts, Others
Use of medical grade collagen in
reconstructive surgery is projected to escalate the medical and research grade
collagen market at a CAGR of 6.7%
Latest
market study on “Global Medical and Research Grade Collagen
Market to 2027 – Analysis and Forecasts By Source (Bovine, Porcine, Poultry,
Marine, Others); Product (Gelatin, Hydrolyzed Collagen, Native Collagen,
Others); Application (Haemostats, Vascular Grafts, Tissue Scaffolds, Cartilage
Repair, Wound Care, Bone Grafts, Others)”. The
global Medical and Research Grade Collagen market is accounted to US$ 495.4 Mn
in 2018 in 2018 and is expected to grow at a CAGR of 6.7% during the forecast
period 2019 – 2027, to account to US$ 884.2 Mn by 2027. The report include key
understanding on the driving factors of this growth and also highlights the
prominent players in the market and their developments.
Under the application segment, the bone graft segment
accounted for the largest share in the global medical and research grade
collagen market. The adoption of bone grafting surgical procedures to replace
missing bones and repair bone fractures which are extremely complex, and pose a
significant health risk to the patient is gaining wider acceptance in the
orthopaedic field. Collagen is used in bone grafts as it has a triple helical
structure which makes it a very strong molecule. This makes it an ideal bio-material
to replace broken bones, without compromising on the structural integrity of
the skeleton. The rising use of bio-materials such as collagen in the
preparation of bone grafts is expected to drive global medical and research
grade collagen market.
Collagen is the major fibrous protein in the
extra-cellular matrix and connective tissues. More than 80% of the skin is
composed of collagen. Collagen is also the main component of the ligaments and
tendons. Collagen can be used as a biological skin substitute. Biological
properties such as low antigenicity, no toxicity and minimal biodegradation
make it a favorable biomaterial in applications such as reconstructive
surgeries. Collagen scaffolds have been widely used in the field of tissue
engineering. However, the poor mechanical property of collagen scaffolds has
limited its applications in tissue engineering and reconstructive surgery to
some extent. To overcome this shortcoming, collagen scaffolds are being
cross-linked by chemical or physical processes or modified with natural or
synthetic polymers and inorganic materials. Collagen is used to form a matrix
of regenerating tissues for treating burn injuries, and growing damaged
tissues. The rise in the aging population across the world, and growing
incidences of age related diseases such as osteoporosis, arteriosclerosis,
cancer etc. is expected to drive the market for bio-materials such as collagen
used in reconstructive surgeries.
The market for global medical and research grade collagen
is concentrated with some very well-established players. Some of the key
players in the global medical and research grade collagen market include
Advanced Biomatrix Inc., Collagen Matrix, Inc., Collagen Solutions Plc,
Cologenesis Healthcare Pvt Ltd, Croda International Plc, DSM, INNOCOLL, Integra
Lifesciences, Nitta Gelatin Na Inc. and Rousselot among others.
Comments
Post a Comment